ATXN3 and movement disorder: Features of movement disorders are among the most common co‐existing nonataxic symptoms in SCA, especially SCA3 (Garcia Ruiz, Mayo, Hernandez, Cantarero, & Ayuso, 2002; Schols et al., 2000).